Deep, research-use-only reference pages on 45+ research compounds — mechanisms, head-to-head comparisons, handling, purity, and the current PubMed & ClinicalTrials.gov publication landscape. A growing library of 1,000+ pages for laboratory professionals.
IGF-1 LR3 is a long-acting insulin-like growth factor-1 analog extensively studied for its distinct modulation of IGF-1 receptor signaling and protein synthesis pathways in various research models.
IGF-1 LR3 is a modified insulin-like growth factor-1 analog extensively studied for its prolonged half-life and potent interaction with the IGF-1 receptor within the somatotropic axis.
IGF-1 LR3 is a long-acting IGF-1 analog extensively studied in cellular and molecular research for its profound influence on IGF-1 receptor signaling and protein synthesis pathways.
MK-677, also known as Ibutamoren, is an orally active ghrelin receptor agonist and growth hormone secretagogue frequently studied for its modulatory effects on the somatotropic axis and downstream IGF-1 signaling.
MK-677 (Ibutamoren), an orally active ghrelin-receptor agonist and growth-hormone secretagogue, serves as a significant tool in anabolic-signaling research due to its capacity to influence endocrine pathways.
Hexarelin is a synthetic growth-hormone-releasing hexapeptide primarily investigated for its interactions with ghrelin receptors, making it a valuable tool in anabolic-signaling research.
Hexarelin, a synthetic growth-hormone-releasing hexapeptide, is a key focus in endocrine research due to its GH secretagogue activity via ghrelin receptors.
GHRP-6 serves as a pivotal research compound for investigating growth hormone secretagogue receptor activation and its subsequent influence on anabolic signaling pathways across various experimental models.
GHRP-2 (Pralmorelin) is a synthetic growth-hormone-releasing peptide investigated in various research contexts, particularly concerning its interaction with the ghrelin receptor and its influence on the somatotropic axis and downstream IGF-1 signaling.
Ipamorelin is a selective growth-hormone secretagogue and ghrelin-receptor agonist extensively investigated in endocrine and metabolic research settings.
